Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)

NCT01617200 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Asenapine
DRUG: Placebo Asenapine
DRUG: Olanzapine
DRUG: Placebo Olanzapine

Sponsor

Forest Laboratories